Vicus Capital’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Vicus Capital's IBD Position: Q2 2026 in Review
Vicus Capital increased its Inspire Corporate Bond ETF (IBD) stake by 7.1% in Q2 2026, buying an estimated $145K and bringing the position to 90,985 shares worth $2.16M. The position accounts for 0.14% of the portfolio, ranked #80.
Vicus Capital first reported a position in IBD in Q1 2023 and has held it in 14 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Vicus Capital held 90,985 shares of Inspire Corporate Bond ETF worth $2.16M as of Q2 2026.
- Vicus Capital bought 6,060 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $145K.
- Inspire Corporate Bond ETF made up 0.14% of Vicus Capital's portfolio in Q2 2026, its #80 holding.
- Vicus Capital first reported a position in Inspire Corporate Bond ETF in Q1 2023 and has held it in 14 quarters since.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Vicus Capital's 13F filing for Q2 2026, filed 5 Aug 2026.